|
|
||||||||
The Journal of Immunology, Vol 152, Issue 5 2289-2297, Copyright © 1994 by American Association of Immunologists
ARTICLES |
TJ Sayers, TA Wiltrout, MJ Smyth, KS Ottaway, AM Pilaro, R Sowder, LE Henderson, H Sprenger and AR Lloyd
Biological Carcinogenesis and Development Program, PRI/DynCorp, Frederick, MD 21702.
We have biochemically purified a 27-kDa serine protease (designated RNK- Tryp-2) from the granules of the rat large granular lymphocyte leukemia cell line (RNK-16) which has tryptase activity. Utilizing molecular sieve chromatography and reverse-phase HPLC, we purified RNK-Tryp-2 to homogeneity and sequenced 33 NH2-terminal amino acids. Oligonucleotide primers were used in the PCR to generate a 528-bp cDNA clone encoding a novel serine protease from RNK-16 mRNA. This cDNA clone was used to isolate an 884-bp RNK-Tryp-2 cDNA from an RNK-16 lambda-gt11 library. The open reading frame predicts a mature protein of 233 amino acids which does not have potential sites for N-linked glycosylation. The cDNA encodes a leader peptide of at least 25 amino acids. The characteristic Ile-Ile-Gly-Gly amino acids of the N-terminus, and the His, Asp, and Ser amino acids that form the catalytic triad of serine proteases, are conserved. The amino acid sequence has less than 45% identity with any other member of the serine protease family, indicating that RNK-Tryp-2 is distinct protease. Southern blot analysis suggests the existence of one or more related genes. A single 1.3-kb mRNA transcript was detected by Northern blot analysis of total cellular RNA from the in vivo passaged RNK-16, rat splenocytes, lung and liver nonparenchymal cells, as well as in highly purified rat LGL and T cells. RNK-Tryp-2 is a novel serine protease that is expressed in the granules of large granular lymphocytes.
This article has been cited by other articles:
![]() |
E. Wilharm, M. A. A. Parry, R. Friebel, H. Tschesche, G. Matschiner, C. P. Sommerhoff, and D. E. Jenne Generation of Catalytically Active Granzyme K from Escherichia coli Inclusion Bodies and Identification of Efficient Granzyme K Inhibitors in Human Plasma J. Biol. Chem., September 17, 1999; 274(38): 27331 - 27337. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Shresta, P. Goda, R. Wesselschmidt, and T. J. Ley Residual Cytotoxicity and Granzyme K Expression in Granzyme A-deficient Cytotoxic Lymphocytes J. Biol. Chem., August 8, 1997; 272(32): 20236 - 20244. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Shresta, J. H. Russell, and T. J. Ley Mechanisms Responsible for Granzyme B-Independent Cytotoxicity Blood, June 1, 1997; 89(11): 4085 - 4091. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |